Following the sell-out success of the CRDN summit in 2016, the Cambridge Rare Disease Network is once again bringing International leaders and local experts together in Cambridge to bridge the gap between research, industry, business and patient groups.


Kay Parkinson, CEO of CRDN, Director of Alström Europe and Founder of Alström UK
Sanjay Patel, Clinical Development Senior Director for Prometic Pharma SMT Ltd.
Owen Vaughan, Regulatory Affairs Senior Director for ProMetic Pharma SMT
Neil Dugdale, General Manager, UK and RoI, of Sobi
Dr. Ségolène Aymé, Medical geneticist and Founder of Orphanet
Dr. Kate Bushby, Professor of Neuromuscular Genetics at Newcastle University John Walton Centre for Muscular Dystrophy Research
Dr. Ana Mingorance, Scientific Advisor to the Dravet Syndrome European Federation
Daniel Lewi, Founder of The Cure & Action for Tay-Sachs (CATS) Foundation
Alastair Kent OBE, Director of Rare Disease UK and Genetic Alliance UK, Chair of CRDN
Dr. Ignacio Hernández Medrano, Clinical Neurologist at Ramon y Cajal Hospital, Madrid